368 related articles for article (PubMed ID: 19581336)
1. Review of the evidence for a colorectal cancer screening programme in elderly people.
Quarini C; Gosney M
Age Ageing; 2009 Sep; 38(5):503-8. PubMed ID: 19581336
[TBL] [Abstract][Full Text] [Related]
2. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
3. Prospects for population colorectal cancer screening in New Zealand.
Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C
N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251
[TBL] [Abstract][Full Text] [Related]
4. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
Nnoaham KE; Lines C
Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening: health impact and cost effectiveness.
Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
Am J Prev Med; 2006 Jul; 31(1):80-9. PubMed ID: 16777546
[TBL] [Abstract][Full Text] [Related]
6. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence.
Walter LC; Lewis CL; Barton MB
Am J Med; 2005 Oct; 118(10):1078-86. PubMed ID: 16194635
[TBL] [Abstract][Full Text] [Related]
8. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
9. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
[TBL] [Abstract][Full Text] [Related]
10. The role of primary care in colorectal cancer screening: experience from Czech Republic.
Seifert B; Zavoral M; Fric P; Bencko V
Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening in elderly patients: when should be more useful?
Pasetto LM; Monfardini S
Cancer Treat Rev; 2007 Oct; 33(6):528-32. PubMed ID: 17553621
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening and treatment: review of outcomes research.
Provenzale D; Gray RN
J Natl Cancer Inst Monogr; 2004; (33):45-55. PubMed ID: 15504919
[TBL] [Abstract][Full Text] [Related]
13. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
[TBL] [Abstract][Full Text] [Related]
15. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
Jansen JB; van Rossum LG; Laheij RJ
Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening in an expanding panorama of screening programmes.
Hoff G
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
[TBL] [Abstract][Full Text] [Related]
17. [Evidence-based planning: the case of mass screening for colorectal cancer in the Lazio region of Italy].
Federici A; Borgia P; Guasticchi G
Ann Ig; 2005; 17(4):313-22. PubMed ID: 16156391
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
19. Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validity.
Watine JC; Bunting PS
Clin Biochem; 2008 May; 41(7-8):459-66. PubMed ID: 18226597
[TBL] [Abstract][Full Text] [Related]
20. [Colorectal cancer screening programme in France, role of the National Institute of Cancer].
Viguier J; Nathan Mle Q
Med Sci (Paris); 2009 Mar; 25 Spec No 1():45-52. PubMed ID: 19361412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
